Caricamento...
Cetuximab Immunoliposomes enhance Delivery of 5-FU to Skin Squamous Carcinoma Cells
Topical chemotherapy of skin cancers is a promising strategy for reduction of side effects and for improvement of patient compliance. The combination of the chemotherapeutic 5-fluouracil (5-FU) and the anti-EGFR antibody cetuximab is a strategy to inhibit tumor growth. Their skin penetration, howeve...
Salvato in:
| Pubblicato in: | Anticancer Agents Med Chem |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5124425/ https://ncbi.nlm.nih.gov/pubmed/27225449 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|